Matthew Monberg

Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma

Lee M. Krug, Harvey I. Pass, Valerie W. Rusch et al. · Journal of Clinical Oncology · 2009 · 464 citations

Medicine, Oncology, Surgery +12

Open-Label Study of Pemetrexed Alone or in Combination with Cisplatin for the Treatment of Patients with Peritoneal Mesothelioma: Outcomes of an Expanded Access Program

Pasi A. Jänne, Antoinette J. Wozniak, Chandra P. Belani et al. · Clinical Lung Cancer · 2005 · 214 citations

Medicine, Oncology, Chemotherapy +3

Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer

Craig H. Reynolds, Coleman K. Obasaju, Michael J. Schell et al. · Journal of Clinical Oncology · 2009 · 172 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized Phase II Trial of Pemetrexed Combined With Either Cisplatin or Carboplatin in Untreated Extensive-Stage Small-Cell Lung Cancer

Mark A. Socinski, Charles Weissman, Lowell L. Hart et al. · Journal of Clinical Oncology · 2006 · 81 citations

Medicine, Oncology, Pharmacology +14

Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial

Bradley J. Monk, Krishnansu S. Tewari, Coraline Dubot et al. · The Lancet Oncology · 2023 · 70 citations · Full text

Medicine, Oncology, Pharmacotherapy +11